Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

Europe Point of Care Testing Devices Market is Expected to Reach EUR 7.2 Billion by 2022 Owing to Promising Growth in Demand of Infectious, Cardiac and Drug of Abuse POCT Devices: Ken Research


GURUGRAM, India, July 17, 2018 /PRNewswire/ --

Key Takeaway from Ken Research Report titled, "Europe POCT Devices Market Outlook to 2022"

POCT market in Europe has been estimated to grow registering a CAGR of close to 6% in the forecast period. This growth would be supported by the launch of new products, entry of new players, innovative technological revolution and increase in reliability on POCT products by home patients & institutional buyers. Technology innovation in molecular diagnostics is a major driver within the infectious disease POCT for HAIs and STDs. HIV-1, HCV, c.difficle, Chlamydia, H. Pylori, Strep A/B, Influenza A/B, RSV, Ebola and Zika have widespread in Europe during the review period. Highly sensitive cardiac troponins that are the efficacy equivalent to centralized lab testing will increase the adoption of POC cardiac markers in POC settings. CK-MB, myoglobin, BNP, NT-proBNP and D-dimers are simultaneously being used in emergency settings. Inevitable pharamcoeconomic benefits in POC cardiac testing propels this segment to achieve its highest growth potential. Increase in reliability & trust in POCT devices by home users & hospitals, more incidence of diseases such as HIV, infectious, cardiac and others, increase in the number of hospitals, clinics, pathology labs in Europe, growth in nano technology and chip-on-phone miniaturization would provide major thrust to the market.

     (Logo: https://mma.prnewswire.com/media/661352/Ken_Research_Logo.jpg )

Ken Research in its latest study "Europe POCT Devices Market Outlook to 2022 - by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients)" suggests that the demand for POCT devices would continue to grow owing to rising health awareness, launch of various new POCT products and expanding sales through internet portals.

Keywords  

Key Topics Covered: 

Key Companies Covered: 

For more information on the research report, refer to below link:

https://www.kenresearch.com/healthcare/medical-devices/europe-poct-devices-market/149664-91.html

Related Reports by Ken Research 

Vietnam Medical Devices Market Outlook to 2022 - By Equipments (Consumables, Diagnostic Imaging, Dental Products, Orthopedics and Prosthetics, Patient Aids and Other Medical Devices) 

The report provides a comprehensive analysis of Vietnam Medical Devices Market Overview and Size, growth drivers and restraints. 

Indonesia Medical Devices Market Outlook to 2022 - By Medical Consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices, By Imports & Domestic Production 

The report provides information on medical device market segment, competitive landscape of major medical device manufacturers  

Global Robotic Surgery Market by Region (North America, Europe, Asia Pacific and ROW), by Product Type (Surgical Robot System, Instruments and Accessories and Services) - Outlook to 2022 

The report covers aspects such as robotic surgery market by its key segments including market size by regions, product type, application and brands.  

Contact Us :
Ken Research
Ankur Gupta
Head Marketing & Communications
[email protected]
+91-9015378249


SOURCE Ken Research


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: